Nicholas Galakatos, 10% Owner at AVANIR PHARMACEUTICALS, INC. (AVNR), sold 551,838 shares at $3.47 ($1.9M) on 2010-10-08, disclosed to the SEC on 2010-10-12.
Open-market sale of $1.9M AVNR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.47 | 240,838 | $836K | 43.3% |
| 2 | $3.52 | 311,000 | $1.1M | 56.7% |
| Total | $3.50 avg | 551,838 | $1.9M | 100% |
| Filing → |
| FTSV | BUY | 2018-07-02 | $3.2M | — | Filing → |
| OPHT | SELL | 2016-01-13 | $197K | — | Filing → |
| OPHT | SELL | 2015-12-14 | $193K | — | Filing → |